Floatz logo

Tamoxifen

Pancreatic Mucinous-Cystic Neoplasm

University of NebraskaSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pancreatic Mucinous-Cystic Neoplasm cohort.

Asset / SponsorPhaseRating
Ethylicum
Samsung Medical Center
Phase 2B

Same molecule, other indications

Tamoxifen is also rated in:

breast carcinomaActive
BBB
Indicative · Phase 4
75 / 100
View asset →
invasive breast carcinomaActive
BBB
Indicative · Phase 4
75 / 100
View asset →
breast fibroadenomaDormant
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →